U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8966989669Obstructive Sleep Apnea and Genes ExpressionRecruitingNo Results AvailableObstructive Sleep ApneaProcedure: Continuous Positive Airway Pressure (CPAP)https://ClinicalTrials.gov/show/NCT01392339
8967089670Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)CompletedNo Results AvailablePsoriatic ArthritisDrug: Secukinumab (75 mg)|Drug: Secukinumab (150 mg)|Drug: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT01392326
8964189641A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: rituximab [MabThera/Rituxan]https://ClinicalTrials.gov/show/NCT01392716
8964289642Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed FormulationsCompletedHas ResultsPharmacokinetic Study in Healthy ParticipantsDrug: Dasatinib as tablets|Drug: Dasatinib as liquid|Drug: Dasatinib as dispersed tabletshttps://ClinicalTrials.gov/show/NCT01392703
8964389643Evaluation of a Primary Prevention Program for Anxiety Disorders Using Story BooksCompletedNo Results AvailableAnxietyBehavioral: Dominique's Handy Trickshttps://ClinicalTrials.gov/show/NCT01392690
8964489644Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaCompletedHas ResultsType 2 Diabetes Mellitus|High HbA1c Level|Inadequate Glycaemic ControlDrug: dapagliflozin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01392677
8964589645TVTO Versus TVTFFM for Urinary Stress IncontinenceCompletedNo Results AvailableUrinary Stress Incontinence Treated by TVThttps://ClinicalTrials.gov/show/NCT01392664
8964689646Tension-free-vaginal-tape-obturator (TVTO) Versus Tension-free-vaginal-tape-Secur (TVTS) for Treatment of SUICompletedNo Results AvailableUrinary Stress Incontinencehttps://ClinicalTrials.gov/show/NCT01392651
8964789647Effects of Sildenafil in Resistant Hypertensives and Genetic PolymorphismCompletedNo Results AvailableHypertensionOther: sugar pill|Drug: sildenafilhttps://ClinicalTrials.gov/show/NCT01392638
8964889648PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)Active, not recruitingNo Results AvailableNon-ischemic Dilated CardiomyopathyProcedure: Transendocardial injection|Biological: Autologous hMSCs|Biological: Allogeneic hMSCshttps://ClinicalTrials.gov/show/NCT01392625
8964989649Erythropoietin and Platelet Activation MarkersCompletedNo Results AvailableThrombosis|HypertensionDrug: erythropoietinhttps://ClinicalTrials.gov/show/NCT01392612
8965089650Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II)RecruitingNo Results AvailableCRPS Type IIProcedure: SUBCUTANEOUS VENOUS SYMPATHECTOMY (RSVS)https://ClinicalTrials.gov/show/NCT01392599
8965189651Systemic Therapy With or Without Upfront Surgery in Metastatic Breast CancerTerminatedNo Results AvailableMetastatic Breast CancerProcedure: upfront breast surgery|Other: systemic therapyhttps://ClinicalTrials.gov/show/NCT01392586
8965289652A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin degludec/liraglutide|Drug: insulin degludechttps://ClinicalTrials.gov/show/NCT01392573
8965389653Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal HyperfiltrationCompletedHas ResultsDiabetes Mellitus, Type 1Drug: BI 10773https://ClinicalTrials.gov/show/NCT01392560
8965489654Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsCompletedHas ResultsCongenital Bleeding Disorder|Haemophilia A With Inhibitors|Haemophilia B With InhibitorsDrug: vatreptacog alfa (activated)|Drug: eptacog alfa (activated)https://ClinicalTrials.gov/show/NCT01392547
8965589655Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life SettingCompletedNo Results AvailablePrimary HypertensionDrug: Telmisartan/hydrochlorothiazide (Pritor Plus, BAY98-7103)https://ClinicalTrials.gov/show/NCT01392534
8965689656Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced CancerCompletedNo Results AvailableNeoplasmsDrug: Copanlisib + Refametinib (BAY86-9766)|Drug: Copanlisib + Refametinib (BAY86-9766)https://ClinicalTrials.gov/show/NCT01392521
8965789657IMproved PREdiction of Severe Sepsis in the Emergency DepartmentCompletedNo Results AvailableSystemic Inflammatory Response Syndrome (SIRS)|Sepsis|Severe Sepsis|Septic Shockhttps://ClinicalTrials.gov/show/NCT01392508
8965889658Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)TerminatedHas ResultsPulmonary Arterial HypertensionDrug: Imatinibhttps://ClinicalTrials.gov/show/NCT01392495
8965989659IBIS: Italian Burden of Illness on Schizophrenia & Bipolar DisorderCompletedNo Results AvailableSchizophrenia|Bipolar Disorderhttps://ClinicalTrials.gov/show/NCT01392482
8966089660Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension PatientsCompletedNo Results AvailablePulmonary Arterial HypertensionDrug: Imatinibhttps://ClinicalTrials.gov/show/NCT01392469
8966189661Validation and Cross-Cultural Adaptation of the Romanian Version of Oral Health Impact Profile in Edentulous AdultsCompletedNo Results AvailableSevere Atrophy of the Edentulous MandibleProcedure: Insertion of two screw type dental implantshttps://ClinicalTrials.gov/show/NCT01392456
8966289662Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFActive, not recruitingNo Results AvailablePrimary Myelofibrosis (MF)|Post-Polycythemia Vera (PV) MF|Post-Essential Thrombocythemia (ET) MFDrug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT01392443
8966389663Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected PatientsCompletedNo Results AvailableHIV InfectionOther: Discontinuation of prophylactic drugs i.e. co-trimoxazole, dapsone, fluconazole, itraconazole, azithromycinhttps://ClinicalTrials.gov/show/NCT01392430
8966489664Anterior Prolift Versus Posterior Prolift for Pelvic Floor ProlapseCompletedNo Results AvailablePelvic Floor Prolapsehttps://ClinicalTrials.gov/show/NCT01392417
8966589665Exercise For Sub-acute Stroke Patients in JamaicaRecruitingNo Results AvailableStrokeProcedure: Task Oriented Exercise Training|Procedure: Stroke Care "Get with the Guidelines"https://ClinicalTrials.gov/show/NCT01392391
8966689666Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®CompletedHas ResultsPneumococcal VaccinesBiological: 13-valent pneumococcal conjugate vaccine|Biological: INFANRIX hexa|Drug: Paracetamol|Biological: 13-valent pneumococcal conjugate vaccine|Biological: INFANRIX hexa|Drug: Ibuprofen|Biological: 13-valent pneumococcal conjugate vaccine|Biological: INFANRIX hexa|Drug: Paracetamol|Biological: 13-valent pneumococcal conjugate vaccine|Biological: INFANRIX hexa|Drug: Ibuprofen|Biological: 13-valent pneumococcal conjugate vaccine|Biological: INFANRIX hexahttps://ClinicalTrials.gov/show/NCT01392378
8966789667Development of a Score for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's DiseaseRecruitingNo Results AvailableCrohn's Disease|Intestinal Tuberculosishttps://ClinicalTrials.gov/show/NCT01392365
8966889668HYPAZ: Hypertension Induced by PazopanibTerminatedNo Results AvailableRenal Cell Carcinoma|Soft Tissue Sarcoma|Glioblastoma|Ovarian Cancer|Cervical Cancer|Breast Cancer|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Pancreatic Cancer|Melanoma|Gastrointestinal CancerDrug: Pazopanibhttps://ClinicalTrials.gov/show/NCT01392352

* Görseller ve İçerik tekif hakkına sahip olabilir